Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Journal of the American Society of Cytopathology|May 2, 2018
PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?Vanda F Torous, Deepa Rangachari, Benjamin P Gallant, et al.Cancer Treatment and Research Communications|September 13, 2018
Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitisMeghan Shea, Deepa Rangachari, Robert W Hallowell, et al.Gynecologic Oncology Reports|March 4, 2024
Oxaliplatin desensitization for ovarian cancer in pregnancy: A case reportKaitlin Nicholson, Lily Jia, Margaret Rowe, et al.Revista Panamericana De Salud Publica = Pan American Journal of Public Health|October 11, 2023
Storytelling workshop to encourage stakeholder engagement with the Global Initiative for Childhood CancerSoad Fuentes-Alabí, Kendall Carpenter, Meghan Shea, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2017
Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung AdenocarcinomaDeepa Rangachari, Paul A VanderLaan, Meghan Shea, et al.JAMA Network Open|February 11, 2021
Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab MonotherapyKartik Sehgal, Ritu R Gill, Page Widick, et al.Cancers|March 28, 2024
A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical PracticeHollis Viray, Andrew J Piper-Vallillo, Page Widick, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2021
Evaluating meaningful levels of financial toxicity in gynecologic cancersKatharine McKinley Esselen, Annika Gompers, Michele R Hacker, et al.Gynecologic Oncology|January 20, 2020
Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single family and comparison of large cohortsYamicia D Connor, Diana Miao, Douglas I Lin, et al.JCO Clinical Cancer Informatics|June 7, 2021
Implementing Electronic Patient-Reported Outcomes for Patients With New Oral Chemotherapy Prescriptions at an Academic Site and a Community SiteJim W Doolin, Jonathan L Berry, Natalia S Forbath, et al.Pageof 4